InstantWhyThe numbers
Yahoo Finance reports that Microsoft's cloud revenue continues to climb, prompting analysts to reassess the stock's valuation after its recent rally. The article examines whether the shares remain attractive following strong Azure performance. Microsoft has been a major beneficiary of enterprise cloud migration and AI infrastructure spending.
Why it matters
Cloud revenue has become the primary driver of Microsoft's market value, accounting for the bulk of its growth as traditional software sales mature. Investors are weighing whether Azure's trajectory justifies the current multiple or whether the risk-reward has shifted after the stock's run.
How this compares
Microsoft shares posted their biggest one-day gain since 2008 on 30 July 2026 after Azure crossed a revenue milestone, adding hundreds of billions in market value as new OpenAI disclosures eased concerns about AI spending returns. The cloud business has repeatedly beaten estimates, convincing investors that the company's data centre buildout will generate returns without burning cash. Azure growth has become the single most watched metric in Microsoft earnings, with each quarterly print moving the stock more than Windows or Office results.
What to watch
The valuation debate will be settled by whether Azure can sustain its growth rate as the business scales and competition from Amazon Web Services and Google Cloud intensifies. Microsoft's next earnings report will show whether cloud momentum is accelerating or beginning to normalise. Analysts will also watch whether AI workloads are translating into durable revenue or remain experimental spending by early adopters.
- ✓Detected and written at 2026-08-04 03:08
- ✓First reported by Yahoo Finance
- ✓Written from public facts in our own words — never a copy
- ✓Published as fast as possible; our team holds editorial responsibility
Sources
- Yahoo Finance — Headlines: https://finance.yahoo.com/markets/stocks/articles/cloud-revenue-soars-time-buy-163500803.html
More stories
InstantWhyProcter & Gamble to acquire supplements brand Thorne in health business expansion
InstantWhyTwo charged in federal drug trafficking probe in southern Maryland
InstantWhy